Skip to main content

Table 2 Peri-interventional anticoagulation

From: Pulsed electron avalanche knife (PEAK) PlasmaBlade™ in pacemaker and defibrillator procedures

Anticoagulation

n (%)

VKAa

87 (30.9)

NOAC

15 (5.3)

 Rivaroxaban

8 (2.8)

 Edoxaban

2 (0.7)

 Apixaban

15 (5.3)

 Dabigatran

0 (0)

DAPT

55 (19.5)

Triple therapy

6 (2.1)

  1. VKA vitamin K antagonist, DAPT dual antiplatelet therapy, NOAC novel oral anticoagulant
  2. aMean INR of patients on VKA at the time of the procedure was 1.51 ± 0.37